Loading provider…
Loading provider…
Psychiatry Physician in Costa Mesa, CA
NPI: 1417030222Primary Employer
Gustavo Alva, M.D., a Professional Corporation
gusalvamd.com
HQ Phone
Get M.D. Gustavo's Phone Numberphone_androidMobile
Get M.D. Gustavo's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1995 - 2027
TX State Medical License
2017 - 2026

American Board of Psychiatry and Neurology
Psychiatry
University of California (Irvine)
Residency • Psychiatry
1994 - 1998
Universidad Autonoma de Guadalajara
Medical School
Until 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 312 | 1,931 |
| 2 | 90833Psychotherapy, 30 minutes | 262 | 867 |
| 3 | 96127Brief emotional or behavioral assessment | 202 | 640 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 58 | 87 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 54 | 54 |
Importance of achieving rapid treatment response in major depressive disorder.
Authors: @ValidYN, LastName, ForeName, Initials, Identifier, AffiliationInfo
Journal: CNS Spectr
Publication Date: 2023-03-27
Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease.
Authors: Carmel Armon, Charles Bernick, Alvaro Pascual-Leone, Carl Sadowsky, Andrew Keegan, Marc Agronin, Babak Tousi
Publication Date: 2019-12-28
Lead Sponsor: Athira Pharma
Intervention / Treatment: DRUG: Placebo, DRUG: ATH-1017
Lead Sponsor: Tetra Discovery Partners
Intervention / Treatment: DRUG: Placebo, DRUG: BPN14770
Lead Sponsor: Alector Inc.
Collaborators: AbbVie
Intervention / Treatment: DRUG: Placebo, DRUG: AL002